関連する実験動画
Updated: May 11, 2026

08:28
Experimental Metastasis Assay
Published on: August 25, 2010
まとめ
N-メチル-N'-ニトロニトロスグアニジン (MNNG) 治療は,ヒト骨性肉腫細胞におけるメット・オンコゲンを活性化させた. これには,メットとtprロシの融合が関与し,新しいハイブリッドトランスクリプトを作成し,チロシンキナーゼ遺伝子ファミリーを活性化しました.
科学分野:
- 腫瘍学 腫瘍学
- 分子生物学は分子生物学である.
- 遺伝学 遺伝学とは
背景:
- タイロシンキナーゼ遺伝子の家族の一員であるメト・オンコゲンは,様々な癌の発生に役割を果たしています.
- 腫瘍遺伝子の活性化メカニズムの理解は,標的がん治療の開発に不可欠です.
研究 の 目的:
- N-メチル-Nイトロソニトログアニジン (MNNG) を使用したヒト骨性肉腫 (HOS) 細胞系におけるメット・オンコゲンのインビトロ活性化を調査する.
- 遺伝子の変異と,その結果生じるトランスクリプトの特徴を特定し,腫瘍遺伝子の活性化に関連付けます.
主な方法:
- HOS細胞をMNNGで処理する.MNNGは,クラストゲン性発癌物質として知られている.
- メット・オンコゲン・ロカスのための探査機を用いた遺伝子発現の分析.
- ハイブリッドトランスクリプトを含むRNAトランスクリプトの識別と特徴付け.
主要な成果:
- MNNG治療は,HOS細胞におけるメット腫瘍遺伝子の活性化を誘導した.
- 2つの異なるトランスクリプト (9.0kbと10.0kb) が,メット腫瘍遺伝子の場所から認識されました.
- 新型5.0kbのハイブリッドRNAトランスクリプトが検出され,tprとメットプロトオンコゲンロシウムの融合から生じた.
- 10.0kbのRNAと関連したtprロカスは染色体1にマッピングされ,メット原発がん遺伝子ロカスは染色体7q21-31にマッピングされる.
結論:
- HOS細胞におけるメット・オンコゲンの活性化には,染色体的に異なったメットとtprロシウムの融合が伴う.
- この融合イベントは,新しいハイブリッドトランスクリプトを生成し,メット腫瘍遺伝子の活性化とその関連するチロシンキナーゼ活性化につながります.
- この発見は,染色体再配列による腫瘍遺伝子の活性化メカニズムについての洞察を提供します.
関連する概念動画
Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Cancer-Critical Genes I: Proto-oncogenes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
MAPK Signaling Cascades
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Cancer-Critical Genes I: Proto-oncogenes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...

